Edition:
United States

Celyad SA (CYAD.BR)

CYAD.BR on Brussels Stock Exchange

22.14EUR
20 Nov 2018
Change (% chg)

€-0.82 (-3.57%)
Prev Close
€22.96
Open
€22.80
Day's High
€22.80
Day's Low
€21.38
Volume
34,713
Avg. Vol
31,904
52-wk High
€39.94
52-wk Low
€20.20

Chart for

About

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure,... (more)

Overall

Beta: 1.94
Market Cap(Mil.): €291.63
Shares Outstanding(Mil.): 11.94
Dividend: --
Yield (%): --

Financials

  CYAD.BR Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -6.08 -- --
ROI: -58.57 -0.30 13.58
ROE: -80.62 -2.98 15.11

Earnings vs. Estimates